The Weekly Notable Startup Funding Report takes us on a trip across various ecosystems in the US, highlighting some of the notable funding activity in the various markets that we track. The notable startup funding rounds for the week ending 10/7/23 featuring funding details for Cortica, Pulumi, Stampli, and nine other deals representing $649M in new funding that you need to know about.
Cortica – $40.0M
Cortica provides neurological therapies for children with autism and other developmental differences.
Revio – $2.5M
Revio is a data analytics company that helps banks identify large revenue opportunities from existing customers.
Iambic Therapeutics – $100.0M
Iambic Therapeutics is disrupting the therapeutics landscape with its unique AI-driven drug-discovery platform.
2478 Everyday Investors Shared $1,123,615 Net Profit on a Monet
Now you might be thinking: “what the heck are you talking about?” But keep reading, because this investment platform’s users are already smiling all the way to the bank. Thanks to Masterworks, the award-winning platform for investing in blue-chip art.
Every single one of Masterworks’ 15 sales has returned a profit to investors, for a 100% positive net return track record. With 3 recent sales, Masterworks investors realized net annualized returns of 17.6%, 21.5% and 35%.
How does it work? Simple, Masterworks does all of the heavy lifting like finding the painting, buying it, storing it, and eventually selling it. It files each offering with the SEC so that nearly anyone can invest in highly coveted artworks for just a fraction of the price of the entire piece.
Shares of every offering are limited, but AlleyWatch readers can skip the waitlist to join with this exclusive link.
LEARN MORE
See important disclosures at masterworks.com/cd
Lendbuzz – $45.0M
Lendbuzz is a car financing platform that helps consumers with thin U.S. credit history obtain financing for their car purchase.
Machina Labs – $32.0M
Machina Labs is a mechanical and industrial engineering and manufacturing company that automates metal forming and fabrication processes.
Opsera – $12.0M
Opsera is the provider of the first Continuous Orchestration platform for DevOps practitioners.
The AlleyWatch audience is driving progress and innovation on a global scale. There are a number of options to reach this audience of the world’s most innovative organizations and startups at scale including strategic brand placement, lead generation, and thought leadership in front of an audience that comprises the vast majority of key decision-makers in the NYC business community and beyond. Learn more about advertising to NYC Tech, at scale.
Pulumi – $41.0M
Pulumi is a cloud engineering company that offers a way to build, connect, and run modern cloud applications.
Regent – $60.0M
Regent develops an electric boat-flying machine for coastal transportation.
Stampli – $61.0M
Stampli is an accounts payable automation platform simplifying invoices, approvals, and payments.
2478 Everyday Investors Shared $1,123,615 Net Profit on a Monet
Now you might be thinking: “what the heck are you talking about?” But keep reading, because this investment platform’s users are already smiling all the way to the bank. Thanks to Masterworks, the award-winning platform for investing in blue-chip art.
Every single one of Masterworks’ 15 sales has returned a profit to investors, for a 100% positive net return track record. With 3 recent sales, Masterworks investors realized net annualized returns of 17.6%, 21.5% and 35%.
How does it work? Simple, Masterworks does all of the heavy lifting like finding the painting, buying it, storing it, and eventually selling it. It files each offering with the SEC so that nearly anyone can invest in highly coveted artworks for just a fraction of the price of the entire piece.
Shares of every offering are limited, but AlleyWatch readers can skip the waitlist to join with this exclusive link.
LEARN MORE
See important disclosures at masterworks.com/cd
Stoke Space – $100.0M
Stoke Space is a developer of reusable rockets that provide access to and from any orbit to the satellite industry.
TriNetX – $10.0M
TriNetX is a health research network that connects drug discovery and development from pharmaceutical companies.
Headway – $125.0M
Headway is building a new mental healthcare system that everyone can access.
The AlleyWatch audience is driving progress and innovation on a global scale. There are a number of options to reach this audience of the world’s most innovative organizations and startups at scale including strategic brand placement, lead generation, and thought leadership in front of an audience that comprises the vast majority of key decision-makers in the NYC business community and beyond. Learn more about advertising to NYC Tech, at scale.
